文献速递肾小球疾病

局灶节段性肾小球硬化症循环通透性因子的体外检测

Circulating Permeability Factors in Focal Segmental Glomerulosclerosis: In V itro Detection.
PubMed 文献 · Kidney Int Rep · 2022-09-20

该研究用足细胞和肾小球微血管内皮细胞与不同肾病患者的血浆共孵育,通过体外实验检测循环通透性因子。含推测循环通透性因子的血浆仅在复发期引起足细胞肌动蛋白骨架重排和活性氧过度形成,导致足细胞丢失,而缓解期、激素抵抗型肾病综合征、激素敏感型肾病综合征、膜性肾病及健康对照血浆均未引起上述效应。活性氧清除剂可消除这些效应。作者认为该组体外生物检测可测量足细胞损伤并预测循环通透性因子的存在。

要点

  • 含推测循环通透性因子的复发期血浆引起足细胞肌动蛋白骨架重排和活性氧过度形成,导致足细胞丢失。
  • 上述效应仅见于复发期血浆,不见于健康对照、激素抵抗型肾病综合征、激素敏感型肾病综合征和膜性肾病血浆。
  • 活性氧清除剂二甲基硫脲可消除循环通透性因子血浆的上述效应。

核心结论

  • 作者提供了一组体外生物检测来测量足细胞损伤并预测肾病综合征患者血浆中循环通透性因子的存在,为监测循环通透性因子活性提供了新框架,可能有助于未来肾病综合征诊断或用于疾病监测。
  • 作者认为抑制活性氧形成或促进活性氧快速清除可能对循环通透性因子患者有益。

研究设计与样本

  • 研究将足细胞和肾小球微血管内皮细胞与来自推测含循环通透性因子的局灶节段性肾小球硬化症患者复发期和缓解期血浆、激素抵抗型肾病综合征、激素敏感型肾病综合征、膜性肾病及健康对照的血浆共孵育。
  • 采用Cell Counting Kit-8 assay检测细胞活力,免疫荧光染色检测足细胞肌动蛋白骨架结构,CM-H2DCFDA探针检测活性氧形成,并设或不设活性氧清除剂。

主要发现

  • 含推测循环通透性因子的血浆引起足细胞一系列事件,包括肌动蛋白骨架重排和活性氧过度形成,导致足细胞丢失;肾小球微血管内皮细胞未出现上述事件。
  • 上述效应仅见于复发期收集的循环通透性因子血浆,不见于健康对照、激素抵抗型肾病综合征、激素敏感型肾病综合征和膜性肾病患者血浆。
  • 二甲基硫脲(活性氧清除剂)共同存在时消除了循环通透性因子血浆的上述效应。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The recurrence of proteinuria after kidney transplantation in patients with focal segmental glomerulosclerosis (FSGS) is considered proof of the presence of circulating permeability factors (CPFs). The aim of this study is to demonstrate the presence of plasma CPFs using series of in vitro assays. METHODS: Podocytes and endothelial cells (glomerular microvascular endothelial cells [GMVECs]) were incubated with plasma from FSGS patients with presumed CPFs in relapse and remission and from steroid-resistant nephrotic syndrome (SRNS), steroid-sensitive nephrotic syndrome (SSNS), membranous nephropathy (MN), and healthy controls (hCtrls). Cell viability, podocyte actin cytoskeleton architecture, and reactive oxygen species (ROS) formation with or without ROS scavenger were investigated by Cell Counting Kit-8 assay, immunofluorescence staining, and CM-H2DCFDA probing, respectively. RESULTS: Presumed CPF-containing plasma causes a series of events in podocytes but not in GMVECs. These events include actin cytoskeleton rearrangement and excessive formation of ROS, which results in podocyte loss. These effects were solely observed in response to CPF plasma collected during relapse, but not in response to plasma of hCtrls, or patients with SRNS, SSNS, and MN. The copresence of dimethylthiourea, a scavenger of ROS, abolished the aforementioned effects of CPF plasma. CONCLUSION: We provide a panel of in vitro bioassays to measure podocyte injury and predict the presence of CPFs in plasma of patients with nephrotic syndrome (NS), providing a new framework for monitoring CPF activity that may contribute to future NS diagnostics or used for disease monitoring purposes. Moreover, our findings suggest that the inhibition of ROS formation or facilitating rapid ROS scavenging may exert beneficial effects in patients with CPFs.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Veissi ST, Smeets B, van Wijk JAE, et al. Circulating Permeability Factors in Focal Segmental Glomerulosclerosis: In V itro Detection. Kidney Int Rep. 2022. PMID: 36506233. doi:10.1016/j.ekir.2022.09.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。